Company Filing History:
Years Active: 2015-2016
Title: Anne King: Innovator in Antibody Therapeutics
Introduction
Anne King is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents, her work focuses on innovative solutions for treating cancers and other disorders related to the epidermal growth factor receptor (EGFR).
Latest Patents
Anne King's latest patents include groundbreaking research on antibodies against the epidermal growth factor receptor (EGFR). These patents disclose anti-EGFR antibodies and therapeutic compositions that comprise combinations of these antibodies. The methods outlined in her patents aim to treat EGFR-related disorders, including various types of cancers. This work represents a significant advancement in targeted cancer therapies.
Career Highlights
Anne King is currently associated with Merrimack Pharmaceuticals, Inc., where she continues to push the boundaries of medical research. Her expertise in antibody development has positioned her as a key player in the biotechnology sector. Her innovative approaches have garnered attention and respect within the scientific community.
Collaborations
Some of her notable coworkers include Raghida Bukhalid and Michael Feldhaus. Their collaborative efforts contribute to the advancement of research and development in the field of antibody therapeutics.
Conclusion
Anne King's contributions to the field of biotechnology, particularly in the development of anti-EGFR antibodies, highlight her role as an influential inventor. Her work not only advances scientific knowledge but also holds the potential to improve treatment options for patients with EGFR-related disorders.